A clinical note on sublingual buprenorphine.
De Conno
F
F
Pain Therapy and Palliative Care Division, National Cancer Institute of Milan, Italy.
Ripamonti
C
C
Sbanotto
A
A
Barletta
L
L
D000284:Administration, Oral; D000286:Administration, Sublingual; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002047:Buprenorphine / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009020:Morphine / Q000008:administration & dosage / Q000627:therapeutic use*; D009369:Neoplasms / Q000503:physiopathology*; D010146:Pain / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D010147:Pain Measurement; D011446:Prospective Studies
D002047:Buprenorphine; D009020:Morphine